WCN'26: Industry Spotlight Session: Treating CV risk in CKD: from identification to intervention

Recorded On: 03/29/2026

  • Register
    • Non-member - Free!
    • Member - Free!
    • Subscriber - Free!
    • Free trial - Free!

    Continue

WCN'26: Industry Spotlight Session: Treating CV risk in CKD: from identification to intervention
Organized By: The Boehringer Ingelheim and Eli Lilly and Company Alliance

Key:

Complete
Failed
Available
Locked
Treating CV risk in CKD: from identification to intervention
Open to view video.
Open to view video.
You must register to access.